Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Contenido archivado el 2024-06-18

Genomic sequence variants that correlate with gene expression and different epigenetic patterns modify risk for mTLE+HS

Objetivo

Epilepsy is the second most common neurological disorder after stroke and mesial temporal lobe epilepsy with hippocampal sclerosis (mTLE+HS) represents the most common epilepsy syndrome in adult patient with medically intractable partial epilepsy. Studies of genome-wide association (GWA) with epilepsy are critical to provide an unbiased assessment of genes contributing to disease risk and/or response to treatment. However the results of GWA studies give little information about the underlying disease mechanisms. The proposed research project will try to identify those genomic sequence variants that correlate with gene expression and different epigenetic patterns that could modify risk for mTLE+HS. Starting with an already established epilepsy GWA study, we propose to obtain gene expression and methylation data from 100 biopsy specimens obtained from well-characterized chronic pharmacoresistant mTLE+HS patients, who underwent resection of the temporal lobe at the National Hospital for Neurology and Neurosurgery (NHNN) and for whom we already have whole-genotyping data. Individuals will be matched for age, gender and ethnic background with healthy controls from two ongoing whole genome expression and methylation studies at UCL. The integration of gene expression with genetic variability will provide insights into the causal variants and how this may lead to mTLE+HS. In addition, we will investigate an additional biological mechanism, methylation that could alter an individual's susceptibility to mTLE+HS risk. Our interdisciplinary approach will contribute to the understanding of the molecular mechanisms underlying mTLE+HS pathology. In the long term, this understanding will lead to the preventative identification of high-risk patients and the development of novel therapies, aimed at the prevention of seizures and the cognitive impairment suffered by these patients.

Convocatoria de propuestas

FP7-PEOPLE-2009-RG
Consulte otros proyectos de esta convocatoria

Coordinador

UNIVERSITY COLLEGE LONDON
Aportación de la UE
€ 56 250,00
Dirección
GOWER STREET
WC1E 6BT LONDON

Ver en el mapa

Tipo de actividad
Higher or Secondary Education Establishments
Contacto administrativo
Greta Borg-Carbott (Ms.)
Enlaces
Coste total
Sin datos